|
Markers |
Cells |
n |
Mean |
SD |
Min |
Q1 |
Median |
Q3 |
Max |
p-value |
MMP2 |
Tumor |
37 |
76.05 |
20.14 |
28.58 |
64.81 |
82.99 |
91.39 |
99.96 |
0.1953 |
Stromal |
37 |
69.99 |
18.87 |
6.51 |
62.21 |
72.99 |
84.9 |
97.81 |
MMP9 |
Tumor |
46 |
42.01 |
38.56 |
0.07 |
3.45 |
35.74 |
81.42 |
100.0 |
0.0009 |
Stromal |
46 |
53.2 |
35.51 |
0.07 |
17.89 |
66.23 |
85.74 |
95.41 |
MMP14 |
Tumor |
35 |
85.75 |
25.15 |
3.39 |
83.23 |
100.0 |
100.0 |
100.0 |
< 0.0001 |
Stromal |
35 |
66.06 |
23.79 |
10.9 |
45.64 |
69.83 |
87.49 |
100.0 |
TIMP1 |
Tumor |
46 |
76.53 |
15.08 |
40.26 |
68.03 |
77.66 |
88.45 |
99.65 |
0.0076 |
Stromal |
46 |
83.72 |
11.64 |
59.55 |
76.37 |
84.52 |
93.81 |
100.0 |
TIMP2 |
Tumor |
38 |
37.69 |
24.58 |
0.0 |
17.42 |
37.44 |
49.46 |
88.57 |
< 0.0001 |
Stromal |
38 |
65.11 |
21.73 |
3.13 |
49.08 |
64.21 |
86.38 |
100.0 |
|
Comparisons between means were performed using the paired t-test |
Table 4: Comparison of mean percentages of tumor and stromal cells
immunopositive in Invasive Carcinoma (Group 3) |